Search research articles
Contact Us
Filters
Showing results (1-10 of 233) with videos related to
Page
of 24
Sort By:
Therapeutics and Clinical Risk Management
|
May 10, 2018
Emerging treatment options for the management of pemphigus vulgaris
Khalaf Kridin
Immunologic Research
|
February 27, 2018
Pemphigus group: overview, epidemiology, mortality, and comorbidities
Khalaf Kridin
Journal of the American Academy of Dermatology
|
November 14, 2018
Comment on "Oral diabetes medications other than dipeptidyl peptidase-4 inhibitors are not associated with bullous pemphigoid: A Finnish nationwide case control study"
Khalaf Kridin
Dermatologic Therapy
|
June 8, 2020
Dipeptidyl-peptidase IV inhibitors (DPP4i)-associated bullous pemphigoid: Estimating the clinical profile and exploring intraclass differences
Khalaf Kridin
Indian Journal of Dermatology
|
September 14, 2018
Accessible Diagnostic Methods to Differentiate between Epidermolysis Bullosa Acquisita and Other Subepidermal Autoimmune Bullous Diseases
Khalaf Kridin
Immunologic Research
|
November 22, 2017
Subepidermal autoimmune bullous diseases: overview, epidemiology, and associations
Khalaf Kridin
JID Innovations : Skin Science From Molecules to Population Health
|
December 15, 2021
Epidemiology of Pemphigus
Khalaf Kridin, Enno Schmidt
Frontiers in Medicine
|
November 3, 2018
The Usefulness of Indirect Immunofluorescence in Pemphigus and the Natural History of Patients With Initial False-Positive Results: A Retrospective Cohort Study
Khalaf Kridin, Reuven Bergman
JAMA Dermatology
|
January 10, 2019
Assessment of the Prevalence of Mucosal Involvement in Bullous Pemphigoid
Khalaf Kridin, Reuven Bergman
Journal of the American Academy of Dermatology
|
July 17, 2017
Association between bullous pemphigoid and psoriasis: A case-control study
Khalaf Kridin, Reuven Bergman
Page
of 24
Search research articles
Search
Showing results (1-10 of 233) with videos related to
Sort By:
Page
of 24
Therapeutics and Clinical Risk Management
|
May 10, 2018
Emerging treatment options for the management of pemphigus vulgaris
Khalaf Kridin
Immunologic Research
|
February 27, 2018
Pemphigus group: overview, epidemiology, mortality, and comorbidities
Khalaf Kridin
Journal of the American Academy of Dermatology
|
November 14, 2018
Comment on "Oral diabetes medications other than dipeptidyl peptidase-4 inhibitors are not associated with bullous pemphigoid: A Finnish nationwide case control study"
Khalaf Kridin
Dermatologic Therapy
|
June 8, 2020
Dipeptidyl-peptidase IV inhibitors (DPP4i)-associated bullous pemphigoid: Estimating the clinical profile and exploring intraclass differences
Khalaf Kridin
Indian Journal of Dermatology
|
September 14, 2018
Accessible Diagnostic Methods to Differentiate between Epidermolysis Bullosa Acquisita and Other Subepidermal Autoimmune Bullous Diseases
Khalaf Kridin
Immunologic Research
|
November 22, 2017
Subepidermal autoimmune bullous diseases: overview, epidemiology, and associations
Khalaf Kridin
JID Innovations : Skin Science From Molecules to Population Health
|
December 15, 2021
Epidemiology of Pemphigus
Khalaf Kridin, Enno Schmidt
Frontiers in Medicine
|
November 3, 2018
The Usefulness of Indirect Immunofluorescence in Pemphigus and the Natural History of Patients With Initial False-Positive Results: A Retrospective Cohort Study
Khalaf Kridin, Reuven Bergman
JAMA Dermatology
|
January 10, 2019
Assessment of the Prevalence of Mucosal Involvement in Bullous Pemphigoid
Khalaf Kridin, Reuven Bergman
Journal of the American Academy of Dermatology
|
July 17, 2017
Association between bullous pemphigoid and psoriasis: A case-control study
Khalaf Kridin, Reuven Bergman
Page
of 24